J&J vaccine remains on pause as CDC panel requests more information

[Yo_Mama_Been_Loggin]

An advisory panel to the Centers for Disease Control and Prevention declined to make any new recommendations on the use of the Johnson & Johnson Covid-19 vaccine, which will remain paused as the investigation into rare reports of severe blood clots continues.

Many of the experts on the committee said they did not have enough information at this time to make a decision, particularly while the other two Covid-19 vaccines authorized in the U.S. are widely available and have no such safety concerns.

It will be at least a week until the panel is scheduled to reconvene.

"We do need to better understand the risk, which we know is going to be very rare, very low, but we really don't know exactly how low," or how best to treat the cases, Dr. Beth Bell, a member of the advisory panel and a clinical professor in the department of global health at the University of Washington in Seattle, said during the meeting Wednesday.

https://www.msn.com/en-us/news/us/jandj-vaccine-remains-on-pause-as-cdc-panel-requests-more-information/ar-BB1fEMw3

[onecaliberal]

1. The main reason for the pause is to train clinicians on what to do

The normal treatments for blood clots are contraindicated. I heard a Biden spokesperson on GMA this morning talking about why the pause.

[Ms. Toad]

2. Exactly -

The disorder is closely related to a disorder that is CAUSED by using heparin (the normal treatment for clots).

That - and developing general warnings (clotting is not currently listed as a disorder) and specific ones (to the extend they can figure out the at risk group - which probably includes anyone who has had the heparin-induced variety, or who is aware they have the PF4 antibody.)